View in EDS HTML Full Text PDF Full Text

Tumor-priming CD8+ natural killer T-like cells as an efficient novel cell therapy for relapsed/refractory multiple myeloma.

Saved in:
Bibliographic Details
Title: Tumor-priming CD8+ natural killer T-like cells as an efficient novel cell therapy for relapsed/refractory multiple myeloma.
Authors: Lee, Juheon1 (AUTHOR), Choi, Eunjeong1 (AUTHOR), Han, Bohwa2 (AUTHOR), Kim, Jeong-a1 (AUTHOR), Jung, Dana1 (AUTHOR), Kim, Kyeong-Hee3 (AUTHOR), Oh, Sung Yong4 (AUTHOR), Kim, Sung-Hyun4 (AUTHOR), Ha, Kyung-Soo5 (AUTHOR), Kim, Ji-Hoon5 (AUTHOR), Lee, Ji Hyun4 (AUTHOR) hidrleejh12@gmail.com, cho, Duck6 (AUTHOR) duck.cho@skku.edu, Doh, Junsang2 (AUTHOR) jsdoh@snu.ac.kr, Kim, Seok-Ho1,7 (AUTHOR) cvaccine@dau.ac.kr
Source: Experimental Hematology & Oncology. 9/29/2025, Vol. 14 Issue 1, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21623619
DOI:10.1186/s40164-025-00707-7